Founding member and President of JEM Research Institute
Dr. Mark A. Goldstein is a founding member and President of JEM Research Institute. He began participating in clinical trials in the late 1990s. To date, Dr. Goldstein has participated in over 100 clinical trials, being the Principal Investigator 95 times. Most of these trials have been conducted through JEM Research Institute. Under his guidance, JEM has grown into a substantial clinical research site currently employing more than 40 people. Most of the clinical research being conducted at JEM Research Institute deals with progressive cognitive decline.
Dr. Goldstein was born and raised in New York City. Before graduating from Colgate University, where he received a bachelor’s degree in Biophysics. He received his MD from Emory University School of Medicine in Atlanta. After graduating with his MD, he completed residencies in both Internal Medicine (College of Medicine and Dentistry of New Jersey/Robert Wood Johnson) and Neurology (Stanford University). He is board certified in both Internal Medicine and Neurology. After completing his training, he relocated to south Florida and joined a busy clinical neurology practice. During the next 30 years, Dr. Goldstein helped to grow the practice to 6 physicians.
As a clinical neurologist, Dr. Goldstein served as an Affiliated Assistant Clinical Professor of Neurology at the University of Miami. As a researcher, he is currently a Certified Principal Investigator as well as a Fellow of the Academy of Physicians in Clinical Research.
Dr. Goldstein has served on the board of directors of the Medical Specialists of The Palm Beaches, the largest multispecialty medical group in Palm Beach County. He has also been a member of the executive committee, as well as chairman of the credentials committee, at JFK Hospital in Atlantis. He has been both the Chief of the Division of Neurology and the Director of the Comprehensive Stroke Center at JFK.